Literature DB >> 23265427

Fatal Strongyloides stercoralis infection in a patient with chronic inflammatory demyelinating polyneuropathy.

Jayantee Kalita1, Sanjeev K Bhoi, Usha Kant Misra.   

Abstract

A 50-year-old villager with chronic inflammatory demyelinating polyradiculoneuropathy developed pain abdomen, diarrhea, and vomiting after 8 weeks of prednisolone (40 mg/day) therapy. After 10 weeks, he developed abdominal distension, leucocytosis, thrombocytopenia, liver dysfunction, coagulopathy, and respiratory failure. Stool examination showed larvae of Strongyloides stercoralis. He died in spite of antibiotics, metronidazole, ivermectin, vasopressor, and artificial ventilation. The patients on corticosteroid therapy are at risk of fatal septicemia due to Strongyloides stercoralis hyperinfection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23265427      PMCID: PMC4001593          DOI: 10.1179/2047773212Y.0000000030

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  6 in total

Review 1.  Diagnosis of CIDP.

Authors:  Norman Latov
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

2.  European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision.

Authors:  P Y K Van den Bergh; R D M Hadden; P Bouche; D R Cornblath; A Hahn; I Illa; C L Koski; J-M Léger; E Nobile-Orazio; J Pollard; C Sommer; P A van Doorn; I N van Schaik
Journal:  Eur J Neurol       Date:  2010-03       Impact factor: 6.089

Review 3.  Intestinal strongyloidiasis: recognition, management, and determinants of outcome.

Authors:  Ronald Concha; William Harrington; Arvey I Rogers
Journal:  J Clin Gastroenterol       Date:  2005-03       Impact factor: 3.062

4.  Hyperacute pneumonitis in a patient with overwhelming Strongyloides stercoralis infection.

Authors:  A Casati; G Cornero; S Muttini; M Tresoldi; G Gallioli; G Torri
Journal:  Eur J Anaesthesiol       Date:  1996-09       Impact factor: 4.330

Review 5.  Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review.

Authors:  Laurence Fardet; Thierry Généreau; Jean-Louis Poirot; Bertrand Guidet; Adrien Kettaneh; Jean Cabane
Journal:  J Infect       Date:  2006-03-14       Impact factor: 6.072

6.  Acute respiratory failure due to strongyloidiasis in polymyositis.

Authors:  D J McNeely; T Inouye; P Y Tam; S D Ripley
Journal:  J Rheumatol       Date:  1980 Sep-Oct       Impact factor: 4.666

  6 in total
  2 in total

Review 1.  Clinico-epidemiological spectrum of strongyloidiasis in India: Review of 166 cases.

Authors:  Manisha Paul; Suneeta Meena; Pratima Gupta; Sweta Jha; U Sasi Rekha; V Pradeep Kumar
Journal:  J Family Med Prim Care       Date:  2020-02-28

2.  Development of a rapid serological assay for the diagnosis of strongyloidiasis using a novel diffraction-based biosensor technology.

Authors:  Brian J Pak; Fabio Vasquez-Camargo; Evgeniya Kalinichenko; Peter L Chiodini; Thomas B Nutman; Herbert B Tanowitz; Isabel McAuliffe; Patricia Wilkins; Paul T Smith; Brian J Ward; Michael D Libman; Momar Ndao
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.